Maintain Underweight via residual; pivot from share reduction to put convexity
Underweight rating maintained as posture (residual already at underweight allocation), but action is HOLD RESIDUAL rather than fresh trim. Technical stretch, unresolved CPI/Q3 2026 catalysts, and balance sheet deterioration warrant keeping below-benchmark posture. Execute via convexity rather than further share reduction. Aggressive analyst's full exit rejected (forfeits participation in 20%+ ROE franchise); conservative analyst's 25% trim and $99 stop rejected (still over-trim relative to lessons); neutral analyst's 30% phased trim best on first principles but ignores prior trim accumulation. Price target of $112.0 anchored to Q3 2026 earnings catalyst.
| Position | Action |
|---|---|
| Prior three Underweight trims accumulated; marginal value of fourth trim near zero | Do NOT take additional share reduction |
| Residual position held; CPI print and Q3 2026 earnings approaching | Hedge with short-dated puts at $103-104 strike (~1-1.5% position cost) |
| Confirmed close below $98 on rising volume | Full exit trigger |
SCHW is in an earnings inflection with 42% embedded earnings growth, 20%+ ROE, and a 14x forward P/E that represents asymmetric risk/reward — the bear's technical concerns are tactical noise that will be overwhelmed by accelerating fundamentals.
| Indicator | Value | Signal |
|---|---|---|
| RSI | 72.33 | bearish |
| MACD | 2.80 | neutral |
| MACD Histogram | 0.04 | bearish |
| ATR | 2.15 | neutral |
| 10 EMA | $107.05 | bullish |
| 50 SMA | $98.23 | bullish |
| 200 SMA | $95.71 | bullish |
| Upper Bollinger Band | $110.39 | neutral |
| Middle Bollinger Band | $104.80 | neutral |
| MACD Peak | 3.28 | neutral |
| MACD Histogram Peak | 1.19 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $110.40 on volume exceeding 5-day average
Then: Add 0.5-1% portfolio weight (capped per neutral analyst)
The funding-cost tailwind is structural with multiple more quarters to run
↩ rebuts: “Bear's 'no Fed cuts caps NIM upside' — for Schwab, stable rates preserve the funding-cost tailwind; a higher-for-longer Fed doesn't compress NIM, it maintains the deposit cost advantage”
· concedes: Technical indicators (RSI at 72, MACD histogram rolling over from 1.19 to 0.04) do show some maturity in the uptrend; A pullback to $104-107 would be a better entry; The bear makes a valid tactical timing argument about indicator stretch; SCHW is at 52-week highs and has limited near-term cushion against resistance
SCHW is a peak-cycle trade, not a compounder—the technical setup is exhausted, the forward P/E embeds aggressive sell-side optimism that hasn't been tested, the balance sheet is quietly leveraging to fund receivables growth (replicating 2023 dynamics), and the risk/reward at $109.34 offers 8:1 downside to upside asymmetry.
· concedes: Schwab's operating leverage off the 2023 deposit trough is real; The Q2 print was excellent with strong funding-cost tailwind; The 2023 deposit crisis is over; RSI can technically stay elevated for weeks in powerful trends; A normalized business with strong cash flow has some multiple support; Industry growth (HOOD, IBKR, Fidelity) does provide some institutional validation of the retail brokerage space
→ vs conservative: Forward P/E of 14 at 52-week high with 86% probability of no Fed cuts caps NIM expansion; paying full price versus waiting 10 days for 4.7% discount is leaving money on table
→ vs conservative: Balance sheet receivables surge of 25% tied to growth not stress; 2023 crisis was bank-specific deposit mechanics, not comparable to current managed debt growth with treasury operations absorbing it
→ vs neutral: HOLD with buy on pullback is non-decision masquerading as prudence; either breakout without you or pullback without protective action taken
Support: 107.05 · 104.8 · 101.97 · 98.23 | Resistance: 110.39
SCHW exhibits a strong bullish trend structure with price ($109.34) above all moving averages and MACD positive since 2026-06-16, but the setup is not ideal for new entries due to stretched momentum (RSI 72.33, MACD histogram declining from 1.19 to 0.04) and proximity to upper Bollinger resistance at $110.39. Existing longs should hold with trailing stops near the 10 EMA at $107.05, while new positions should wait for either a confirmed breakout above $110.40 or a pullback to the $104-107 support zone. A drop below the critical 50 SMA at $98.23 would invalidate the medium-term bullish thesis.
Market Cap
$189.1B
52-Week High
$109.66
52-Week Low
$83.96
50-Day Average
$97.82
200-Day Average
$96.02
Dividend Yield
1.19%
Beta
0.75
P/E (TTM)
19.92
Forward P/E
14.01
PEG Ratio
1.09
Price / Book
4.30
EPS (TTM)
$5.49
Forward EPS
$7.80
Profit Margin
38.79%
Operating Margin
52.28%
Return on Equity (ROE)
20.27%
Return on Assets (ROA)
2.07%
Q2'26 Total Revenue
$7.07B
Q2'26 Net Interest Income
$3.36B
Q2'26 Interest Income
$4.15B
Q2'26 Interest Expense
$0.79B
Q2'26 Pretax Income
$3.67B
Q2'26 Net Income
$2.80B
Q2'26 Diluted EPS
$1.54
Q2'26 Revenue YoY Growth
+20.9%
Q2'26 Net Income YoY Growth
+31.7%
Q2'26 EPS YoY Growth
+42.6%
2025 Total Revenue
$23.92B
2025 Net Interest Income
$11.75B
2025 Interest Income
$15.50B
2025 Interest Expense
$3.75B
2025 Net Income
$8.85B
2025 Diluted EPS
$4.65
2024 Net Income
$5.94B
2024 Diluted EPS
$2.99
2023 Net Income
$5.07B
2022 Net Income
$7.18B
Q2'26 Total Assets
$517.27B
Q2'26 Cash & Equivalents
$40.58B
Q2'26 Total Investments
$188.34B
Q2'26 Receivables
$144.85B
Q2'26 Total Liabilities
$467.12B
Q2'26 Total Debt
$37.35B
Q2'26 Stockholders' Equity
$50.15B
Q2'26 Tangible Book Value
$24.36B
Q2'26 Treasury Stock
$21.74B
Q2'26 Operating Cash Flow
$4.30B
Q2'26 Free Cash Flow
$4.12B
Q2'26 Stock Buybacks
$3.05B
Q2'26 Dividends Paid
$0.64B
Q2'26 CapEx
$0.19B
Debt/Equity Ratio
151.1%
Goodwill/Intangibles
~$19.6B
Tax Rate
~23.7%
Interest Expense YoY Change
-17%
Strengths
Concerns
Charles Schwab has completed its post-2023 crisis recovery with record Q2 2026 earnings of $1.54 EPS, representing 42.6% YoY growth driven by net interest income expansion (+19% YoY), declining funding costs (-17% YoY interest expense), and strong operating leverage. The stock trades at a forward P/E of 14.01x against a 20.27% ROE, offering an exceptional 6% annualized capital return yield through buybacks and dividends, making it attractive for long-term investors despite trading near 52-week highs. Key risks include interest rate sensitivity given ~50% revenue exposure to NII, elevated debt levels, and near-term technical limitations at current price levels.